Celecoxib--the debate rages on.
Moodley
I
I
D000329:Advertising; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000592:standards*; D002318:Cardiovascular Diseases / Q000139:chemically induced; D000068579:Celecoxib; D017277:Drug Approval; D004345:Drug Industry; D004346:Drug Information Services; D004348:Drug Labeling; D006801:Humans; D008389:Marketing of Health Services; D011720:Pyrazoles; D013019:South Africa; D013449:Sulfonamides / Q000009:adverse effects / Q000592:standards*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib